GPT Healthcare reported a mixed financial performance for the third quarter ended December 31, 2025, with healthy top-line growth on a year-on-year basis, while profitability moderated due to a sharp rise in operating expenses. All figures have been converted from ₹ lakh to ₹ crore for easier comparison.
During Q3 FY26, revenue from operations stood at ₹120.16 crore, compared with ₹102.21 crore in Q3 FY25, reflecting a solid 17.6% YoY growth. Including other income, total income increased to ₹121.58 crore from ₹104.09 crore in the corresponding quarter last year, marking a YoY rise of 16.8%. The improvement in revenue indicates sustained patient footfall and steady demand across hospital services.
On the cost side, total expenses climbed to ₹108.82 crore in Q3 FY26 versus ₹86.47 crore in Q3 FY25, translating into a sharp 25.9% YoY increase. Higher employee benefit expenses, other operating costs, and depreciation weighed on overall profitability during the quarter.
As a result, profit before tax declined to ₹12.76 crore from ₹17.62 crore in Q3 FY25, registering a YoY fall of 27.6%. After accounting for tax expenses, profit after tax came in at ₹9.37 crore, compared with ₹12.25 crore in the year-ago period, reflecting a 23.5% YoY decline.
